The BDNF-TrkB signaling pathway has been previously demonstrated to modulate brain inflammation and protect against hippocampus injury, suggesting that ADSC-mediated protective effects could be linked to reduced symptoms of depression [98,99]. Here, NTRK2 is linked to depressive disorder.